miltefosine has been researched along with Acute Promyelocytic Leukemia in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hochhuth, C | 1 |
| Berkovic, D | 1 |
| Eibl, H | 2 |
| Unger, C | 1 |
| Doenecke, D | 1 |
| Shoji, M | 1 |
| Raynor, RL | 1 |
| Fleer, EA | 1 |
| Vogler, WR | 1 |
| Kuo, JF | 1 |
2 other studies available for miltefosine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells.
Topics: Antigens, Surface; Antineoplastic Agents; Blotting, Northern; Cell Transformation, Neoplastic; DNA P | 1990 |
Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells.
Topics: Cell Differentiation; Cell Line; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Phospholipid Ethe | 1991 |